Friday, 25 May 2018

You are here

RheumNow Week in Review – 15 July 2016

Dr. Jack Cush reviews highlights from this week's rheumatology news on RheumNow.com.

  1. FDA Approves Xiidra (Lifitegrast), an LFA-1 agonits for Dry Eyes. 
  2. FDA Arthritis Advisory Committee Votes 26-0 to Recommend Approval of Adalimumab Biosimilar (Amgens ABP-501).  
  3. Sandoz Etanercept Biosimilar (GP-2015) Unanimously (20-0) Voted for Approval by FDA Arthritis Advisory Committee.  
  4.  FDA Says Cryotherapy, not approved, lacks evidence and poses risks.  http://rheumnow.com/content/fda-says-cryotherapy-lacks-evidence-poses-risks
  5. Vagal Stimulation Decreases Proinflammatory Cytokine Production and Rheumatoid Disease Activity.  
  6. Lupus panniculitis appears as indurated nodules/plaques with lipoatrophy, usually over the proximal extremities & trunk. Important to get a deep Biopsy.  Usual treatments include hydroxychloroquine, steroid, dapsone, others reviewed. https://t.co/CJ5uJHxtcF
  7. In 428 SpA pts, BMI (obesity) had no effect on ASDAS. BMI weakly correlates with CRP, other PRO's. https://t.co/FcTfEicYpN
  8. Small study of Bactrim in GPA (Wegeners) shows 25% relapse w/ continued Rx vs 45% relapse with Bactrim withdrawal. https://t.co/IQksnzI5mk
  9. German RABBIT registry study >13K pts shows an increased risk of lower GI perforations with Actemra (2.7/1000PY), with a four fold higher risk than other therapys.  Nearly 25% of such patients died. https://t.co/u9A4TRFMso
  10. Prevalence of gout increasing in EU from 1.7% to 2.5%; in the US to 4%. Gout is becoming epidemic. https://t.co/zSSRbTId73
  11. 100k German RA compared to 500k controls: RA patients were vaccinated more; but more pneumonia hospitalizations were seen in regions with low or no vaccination https://t.co/HxOIIOf0rP
  12. 234 RA patients treated with Rituxan for a mean of 28 mos. Showed a retention rate of 57%. Discontinuatoins were associated with higher age, greater swollen joint counts, lack of concomitant MTX use.  https://t.co/QRLR9mgP84

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

The RheumNow Week in Review – Methotrexate CIRT Study (5.25.18)

Dr. Jack Cush reviews this past week's news from RheumNow.com - the risk of Cutaneous and Systemic LE, increasing flu vaccination, higher risk of VTE, MPO predictions, new drug for GIOP and CIRT - MTX in cardiovascular risk patients.

ACR Leaders Lobby Capitol Hill for Help on Rising Costs and Access Barriers in Arthritis Care

Rheumatologists and rheumatology health professionals convened on Capitol Hill this week to urge legislative action on pressing policy issues affecting rheumatology care during the American College of Rheumatology’s Advocacy Leadership Conference, held May 16 -17, 2018 in Washington, D.C.

The RheumNow Week in Review – Modifiable Behavior (5.18.18)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  He discusses opioids, new approval for polyarticular JIA, running and osteoarthritis, and modifiable behaviors that influence outcomes. 

The RheumNow Week in Review - Nonadherence and Astronomic Costs (5.11.18)

Dr. Jack Cush reviews highlights, news and journal articles from the past week on RheumNow.com.

Rising Need for Weight Loss Counseling in Arthritic Patients

The CDC's May 4th MMWR reports that from 2002 to 2014, the prevalence of health care provider counseling for weight loss among adults with arthritis and overweight or obesity increased by 10% (from 35% to 45%).

Among the 54.4 million adults with doctor-diagnosed arthritis in the United States, 32.7% are overweight and 38.1% are obese. Moreover obesity is more prevalent among persons with arthritis than among those who do not have arthritis.